Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine vs Ketamine vs Combination for Resistant Orofacial Pain
NCT07250867Phase 2Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Lidocaine Hydrochloride Injection, without epinephrine, ketamine in Orofacial pain (OFP), sponsored by Assiut University. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrineketamine
03
Conditions
Orofacial pain (OFP)
Beyond the preview
Go deeper on NCT07250867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07250867.